Illinois CancerCare - Pekin Satellite — Pekin, Illinois

Illinois CancerCare - Pekin Satellite is a clinical research site located in Pekin, Illinois, United States 61554.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Illinois CancerCare - Pekin Satellite has participated in 1 clinical trials.

Therapeutic areas: Prostate Cancer.

Sponsors: Sumitomo Pharma America, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pekin

Browse all research sites in Illinois · View every site in Pekin

• Cancer Treatment Center at Pekin Hospital
• Pekin Hospital
• Illinois CancerCare-Pekin
• OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center
• OSF Saint Francis Radiation Oncology at Pekin
• Pekin Cancer Treatment Center
• Pfizer Investigational Site
• Bridgeway
• OSF Radiation Oncology
• Novartis Investigative Site
• Illinois Cancer Care-Pekin

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Illinois CancerCare - Pekin Satellite?

Illinois CancerCare - Pekin Satellite has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Illinois CancerCare - Pekin Satellite conducted?

Illinois CancerCare - Pekin Satellite has 1 clinical trials on record. Their work covers Prostate Cancer.

Is Illinois CancerCare - Pekin Satellite accredited by Crixeo Clinical Trials?

Illinois CancerCare - Pekin Satellite has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Illinois CancerCare - Pekin Satellite?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.